43.5
Eloxx Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
20.1
FY23:
1.55
FY24:
2.98
FY25:
5.27
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.66
FY22:
0.99
FY23:
0.16
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
45.1
FY22:
21.1
FY23:
1.71
FY24:
2.98
FY25:
5.27
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
9.96
FY22:
23.1
FY23:
22.7
FY24:
27.3
FY25:
17.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.8
FY22:
8.69
FY23:
1.61
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.4
FY22:
−10.7
FY23:
−22.6
FY24:
−24.3
FY25:
−11.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
45.1
FY22:
21.1
FY23:
1.71
FY24:
2.98
FY25:
5.27
All amounts in millions USD